{"id":"echinaforce-junior","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions (rare, in echinacea-sensitive individuals)"},{"rate":null,"effect":"Rash"}]},"_chembl":{"chemblId":"CHEMBL521","moleculeType":"Small molecule","molecularWeight":"206.28"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The preparation contains active compounds from Echinacea purpurea (aerial parts and roots) that are believed to enhance innate immune responses by activating macrophages, natural killer cells, and other immune cells. This immune stimulation may reduce infection duration and symptom severity, particularly for common colds and upper respiratory infections in children.","oneSentence":"Echinaforce junior is a herbal preparation derived from Echinacea purpurea that stimulates immune function to help prevent and reduce the severity of upper respiratory tract infections.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:36:02.780Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention and treatment of upper respiratory tract infections in children"},{"name":"Common cold symptom reduction in pediatric populations"}]},"trialDetails":[{"nctId":"NCT05002179","phase":"PHASE4","title":"Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2020-11-20","conditions":"Respiratory Tract Infections, Common Cold","enrollment":122},{"nctId":"NCT02198391","phase":"","title":"Study of Echinaforce Junior Tablets in Children With Acute Colds","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2014-10-15","conditions":"Respiratory Tract Diseases","enrollment":79},{"nctId":"NCT02971384","phase":"PHASE3","title":"Echinacea Junior vs Vitamin C in Children 4-12 Years Old","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2016-11-25","conditions":"Respiratory Tract Infection Viral","enrollment":203},{"nctId":"NCT03070314","phase":"PHASE4","title":"Echinaforce Junior Bioavailability Trial","status":"WITHDRAWN","sponsor":"A. Vogel AG","startDate":"2017-02-20","conditions":"Common Cold","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Echinaforce junior","genericName":"Echinaforce junior","companyName":"A. Vogel AG","companyId":"a-vogel-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Echinaforce junior is a herbal preparation derived from Echinacea purpurea that stimulates immune function to help prevent and reduce the severity of upper respiratory tract infections. Used for Prevention and treatment of upper respiratory tract infections in children, Common cold symptom reduction in pediatric populations.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}